UY36086A - QUINOXALINE COMPOUNDS AND USES OF THE SAME - Google Patents

QUINOXALINE COMPOUNDS AND USES OF THE SAME

Info

Publication number
UY36086A
UY36086A UY0001036086A UY36086A UY36086A UY 36086 A UY36086 A UY 36086A UY 0001036086 A UY0001036086 A UY 0001036086A UY 36086 A UY36086 A UY 36086A UY 36086 A UY36086 A UY 36086A
Authority
UY
Uruguay
Prior art keywords
same
quinoxaline compounds
compounds
subsets
quinoxaline
Prior art date
Application number
UY0001036086A
Other languages
Spanish (es)
Inventor
Kenneth M Gigstad
David P Cardin
Hirayama Takaharu
Hirose Masaaki
Kakei Hiroyuki
Hong Myung Lee
Motoyaji Takashi
Nii Noriyuki
Vyskocil Stepan
Watanabe Hiroyuki
Hu Yongbo
Shi Zhan
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of UY36086A publication Critical patent/UY36086A/en

Links

Abstract

La invención proporciona compuestos de fórmula I y subconjuntos de los mismos: donde T, J, R, R (a la 4), R (a la q), o, R (a al A) y R (a la B) y los subconjuntos de los mismos son tales como se describen en la memoria descriptiva. 10 Los compuestos son inhibidores de NAMPT, y por consiguiente, son útiles para el tratamiento del cáncer, afecciones inflamatorias y enfermedades autoinmunes mediadas por células T.The invention provides compounds of formula I and subsets thereof: where T, J, R, R (at 4), R (at q), or, R (a at A) and R (at B) and The subsets thereof are as described in the specification. The compounds are NAMPT inhibitors, and therefore, are useful for the treatment of cancer, inflammatory conditions and autoimmune diseases mediated by T cells.

UY0001036086A 2014-04-18 2015-04-17 QUINOXALINE COMPOUNDS AND USES OF THE SAME UY36086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461981273P 2014-04-18 2014-04-18

Publications (1)

Publication Number Publication Date
UY36086A true UY36086A (en) 2015-11-30

Family

ID=55018090

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036086A UY36086A (en) 2014-04-18 2015-04-17 QUINOXALINE COMPOUNDS AND USES OF THE SAME

Country Status (2)

Country Link
AR (1) AR100136A1 (en)
UY (1) UY36086A (en)

Also Published As

Publication number Publication date
AR100136A1 (en) 2016-09-14

Similar Documents

Publication Publication Date Title
CO2018007528A2 (en) Heterocyclic compounds as immunomodulators
CO2019008783A2 (en) Cyclic dinucleotide compounds for the treatment of cancer
CL2018001230A1 (en) Osteoarthritis treatment
ECSP19003773A (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
CO2018006662A2 (en) Apeline receptor agonists and methods of use
CL2017002786A1 (en) Cross reference to related requests
CL2017003404A1 (en) Antibacterial compounds
CL2018003123A1 (en) Combination therapy for cancer treatment
SV2017005424A (en) METHODS TO TREAT INFECTIONS BY VIRUS FILOVIRIDAE
CL2017000712A1 (en) Pyrimidinones as inhibitors of factor xia
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
CL2016002394A1 (en) Quinoline derivatives as smo inhibitors
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
CL2018001621A1 (en) Heteroarylhydroxypyrimidinones as apeline receptor agonists (apj)
EA201792205A1 (en) HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
CL2017000792A1 (en) Boronic Acid Derivatives
EA201691594A1 (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS
CL2018000953A1 (en) Compuestos derivados de 2,4-dihidroxi-nicotinamidas, agonistas del receptor de apelina (apj); composicion farmaceutica que los comprende; uso en el tratamiento de enfermedades cardiovasculares.
CL2015003089A1 (en) Bicyclic heterocycles as fgfr inhibitors.
UY34750A (en) ? COMPOUNDS FOR HIV TREATMENT, COMPOSITIONS, PREPARATION METHODS, INTERMEDIARIES AND THERAPEUTIC METHODS ?.
AR101905A1 (en) BICYCLIC COMPOUNDS
UY34201A (en) AZAINDOL COMPOUNDS AND METHODS FOR HIV TREATMENT.
ECSP18012103A (en) COLONY STIMULATING FACTOR RECEPTOR 1 (CSF-1R) INHIBITORS
CL2018001569A1 (en) Heteroaromatic compounds as btk inhibitors

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220617